Non-invasive urine and stool tests for early colorectal cancer diagnosis
Official title: Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile
Run by Institut Investigacio Sanitaria Pere Virgili · NCT06452745 · Data updated 2026-11-12
This study is testing if special urine and stool tests can help find colorectal cancer early in patients who have already had a positive blood test.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 70 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Institut Investigacio Sanitaria Pere Virgili Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Reus, Tarragona and 1 other locations) |
| Status | Recruiting |
| Started | July 20, 2019 |
| Main results expected | June 30, 2030 |
| Study ends | June 30, 2040 |
| Registry record updated | October 2, 2024 |
| Trial ID | NCT06452745 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a positive FOBT result who are being referred for a colonoscopy.
✕Probably not a fit
Patients with other primary cancers diagnosed in the last five years or severe kidney or liver diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to identify specific metabolites in urine and stool samples that can differentiate between patients with colorectal cancer or polyps and healthy individuals. By utilizing metabolomics techniques, the study seeks to develop a cost-effective and non-invasive screening method for early diagnosis of colorectal cancer. The research focuses on patients who have tested positive in a fecal occult blood test (FOBT) and are referred for colonoscopy. The goal is to improve early detection rates and ultimately reduce mortality associated with colorectal cancer.
Why it matters
Potential benefit: If successful, this approach could lead to earlier and more accurate diagnosis of colorectal cancer, improving patient outcomes.
How similar studies have gone: While there have been studies exploring metabolomics in cancer detection, this specific approach focusing on non-invasive urine and stool analysis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a positive FOBT test result from the Colorectal Cancer Early Detection Program and referred for a colonoscopy. Exclusion Criteria: * Patients diagnosed with another primary neoplasm in the last 5 years, with the exception of carcinoma in situ of the cervix or non-melanoma skin cancer. * Patients with severe kidney disease stage IV (creatinine clearance \< 30 ml/min). * Patients with severe active liver disease (hepatitis, cirrhosis). * Refusal to sign informed consent.
Where it's running
-
Hospital Universitari Sant Joan de Reus
Reus, Tarragona, Spain Recruiting -
Hospital Universitari Joan XXIII
Tarragona, Tarragona, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using a microwave device to improve colonoscopy for detecting polyps
This study is testing a new microwave device during colonoscopies to see if it can help doctors find more polyps that might be missed with regular methods.
-
Comparing colonoscopy and stool testing for older adults with colon polyps
This study is testing whether a simple stool test can be just as effective as colonoscopy for monitoring older adults with a history of colon polyps.
-
Colorectal Cancer Screening: a Blood Test for a Better Path to Colonoscopy
A blood-based biomarker test using five ofCS markers is being tested to better sort people who need a colonoscopy from those who don’t.
-
Predicting recurrence of high-risk colorectal polyps using microbiota and metabolites
This study is trying to see if the bacteria and substances in the gut can help predict if high-risk colorectal polyps will come back after they've been removed.
-
Evaluating a computer-aided system for measuring colorectal polyp sizes
This study is testing a new computer program to see if it can measure the size of colorectal polyps more accurately during colonoscopy compared to traditional methods.
-
Blood test for early detection of colorectal cancer and adenomas
This study is testing a new blood test to see if it can help find early signs of colorectal cancer and adenomas in people who are already scheduled for a colonoscopy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.